Evonik Industries AG (FRA:EVK) has been given an average rating of “Hold” by the twenty-two research firms that are presently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is €31.31 ($36.41).

A number of analysts have commented on the stock. Sanford C. Bernstein set a €30.00 ($34.88) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research report on Tuesday, March 5th. JPMorgan Chase & Co. set a €24.50 ($28.49) price target on shares of Evonik Industries and gave the stock a “neutral” rating in a research report on Tuesday, March 5th. Independent Research set a €29.00 ($33.72) price target on shares of Evonik Industries and gave the stock a “neutral” rating in a research report on Tuesday, March 5th. Nord/LB set a €26.00 ($30.23) price target on shares of Evonik Industries and gave the stock a “neutral” rating in a research report on Tuesday, March 5th. Finally, Credit Suisse Group set a €28.00 ($32.56) price target on shares of Evonik Industries and gave the stock a “neutral” rating in a research report on Wednesday, March 6th.

Shares of EVK stock traded up €0.15 ($0.17) during midday trading on Wednesday, reaching €27.08 ($31.49). 702,251 shares of the company were exchanged. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34).

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Featured Story: Growth and Income Funds

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.